{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:48:46Z","timestamp":1794552526153,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Platinum-based drugs exhibit potent anti-tumor efficacy but are limited by low bioavailability, severe toxicity, and resistance. Current therapeutic strategies lack effective solutions due to the unclear molecular mechanisms. Autophagy, with its dual protective\/destructive roles, offers potential to enhance platinum-based chemotherapy, yet its clinical translation for optimizing therapeutic outcomes remains underexplored. To address this challenge, we screened a Natural Compounds Library (NCL) to identify low-toxicity agents that synergize with Cisplatin (Cis). Among 285 autophagy-related candidates, Catharanthine (CA) emerged as a specific autophagy activator model molecule that reduced toxicity and synergistically suppressed gastric cancer (GC) when combined with Cis. Mechanistically, CA promoted organ protection via endoplasmic reticulum stress (ERS)\/AMPK\u03b1-dependent autophagy activation. The CA-Cis combination induced tumor-suppressive effects, including ERS, autophagosome accumulation, and cytoskeletal impairment in cancer cells. Conversely, CA-mediated autophagy protected normal cells, as AMPK\u03b1 knockdown abolished this protection, resulting in DNA damage and apoptosis. These results highlight the dual autophagic flux regulation: tumor cells undergo destructive autophagy, while normal cells experience protective autophagy, establishing a favorable therapeutic balance. We confirmed that the CA-Cis combination activates autophagy through the AMPK\u03b1-ULK1 pathway in both tumor and non-tumor tissues and differentially regulates phosphorylation at serine 757 of ULK1, this differentiation can dramatically modulate autophagy activity, thereby mediating context-dependent dual outcomes of autophagic protection and detrimental effects. These findings elucidate a mechanism whereby CA enhances platinum efficacy by remodeling of autophagic homeostasis in organisms, providing a theoretical basis for optimizing platinum-based regimens. Our study bridges autophagy\u2019s dual functionality with clinical strategy, proposing the combination of specific autophagy activators as a promising approach to overcome platinum resistance and toxicity in GC treatment.<\/jats:p>","DOI":"10.1038\/s41419-026-08703-3","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:49:08Z","timestamp":1776869348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing platinum-based chemotherapy efficacy and safety through combination therapy-mediated remodeling of autophagic homeostasis in gastric cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Guangzhao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaowei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-5450","authenticated-orcid":false,"given":"Erhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-1570","authenticated-orcid":false,"given":"Hongjuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"8703_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07923-3","volume":"16","author":"L Zhou","year":"2025","unstructured":"Zhou L, Wang Z, Huang Y, Zhang X, Jiang H, Guo Z, et al. NLRP12 decreases TRIM25-mediated HK2 degradation to promote glycolysis and H3K18la in gastric cancer. Cell Death Dis. 2025;16:615.","journal-title":"Cell Death Dis"},{"key":"8703_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8703_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019;88:102925.","journal-title":"Bioorg Chem"},{"key":"8703_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108642","volume":"258","author":"M Duan","year":"2024","unstructured":"Duan M, Leng S, Mao P. Cisplatin in the era of PARP inhibitors and immunotherapy. Pharm Ther. 2024;258:108642.","journal-title":"Pharm Ther"},{"key":"8703_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","volume":"102","author":"GY Ho","year":"2016","unstructured":"Ho GY, Woodward N, Coward JI. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit Rev Oncol Hematol. 2016;102:37\u201346.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8703_CR6","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1039\/D1BM00879J","volume":"9","author":"C Xian","year":"2021","unstructured":"Xian C, Chen H, Xiong F, Fang Y, Huang H, Wu J. Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs. Biomater Sci. 2021;9:6023\u201336.","journal-title":"Biomater Sci"},{"key":"8703_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk9878","volume":"10","author":"CYW Sung","year":"2024","unstructured":"Sung CYW, Hayase N, Yuen PST, Lee J, Fernandez K, Hu X, et al. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity. Sci Adv. 2024;10:eadk9878.","journal-title":"Sci Adv"},{"key":"8703_CR8","doi-asserted-by":"publisher","first-page":"13536","DOI":"10.1021\/acsnano.0c05541","volume":"14","author":"Y Yang","year":"2020","unstructured":"Yang Y, Yu Y, Chen H, Meng X, Ma W, Yu M, et al. Illuminating platinum transportation while maximizing therapeutic efficacy by gold nanoclusters via simultaneous near-infrared-I\/II imaging and glutathione scavenging. ACS Nano. 2020;14:13536\u201347.","journal-title":"ACS Nano"},{"key":"8703_CR9","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1021\/acs.nanolett.0c03127","volume":"20","author":"G Chen","year":"2020","unstructured":"Chen G, Yang Y, Xu Q, Ling M, Lin H, Ma W, et al. Self-amplification of tumor oxidative stress with degradable metallic complexes for synergistic cascade tumor therapy. Nano Lett. 2020;20:8141\u201350.","journal-title":"Nano Lett"},{"key":"8703_CR10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1021\/acs.chemrestox.9b00204","volume":"32","author":"L Qi","year":"2019","unstructured":"Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol. 2019;32:1469\u201386.","journal-title":"Chem Res Toxicol"},{"key":"8703_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcp.2019.02.006","volume":"163","author":"N Rashtchizadeh","year":"2019","unstructured":"Rashtchizadeh N, Argani H, Ghorbanihaghjo A, Sanajou D, Hosseini V, Dastmalchi S, et al. AMPK: a promising molecular target for combating cisplatin toxicities. Biochem Pharm. 2019;163:94\u2013100.","journal-title":"Biochem Pharm"},{"key":"8703_CR12","doi-asserted-by":"publisher","first-page":"F777","DOI":"10.1152\/ajprenal.00590.2007","volume":"294","author":"C Yang","year":"2008","unstructured":"Yang C, Kaushal V, Shah SV, Kaushal GP. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Ren Physiol. 2008;294:F777\u201387.","journal-title":"Am J Physiol Ren Physiol"},{"key":"8703_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06891-4","volume":"15","author":"JKM Lim","year":"2024","unstructured":"Lim JKM, Samiei A, Delaidelli A, de Santis JO, Brinkmann V, Carnie CJ, et al. The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation. Cell Death Dis. 2024;15:501.","journal-title":"Cell Death Dis"},{"key":"8703_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41416-020-01039-5","volume":"124","author":"M Piffoux","year":"2021","unstructured":"Piffoux M, Eriau E, Cassier PA. Autophagy as a therapeutic target in pancreatic cancer. Br J Cancer. 2021;124:333\u201344.","journal-title":"Br J Cancer"},{"key":"8703_CR15","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/15548627.2015.1056970","volume":"11","author":"J Zhou","year":"2015","unstructured":"Zhou J, Li G, Zheng Y, Shen HM, Hu X, Ming QL, et al. A novel autophagy\/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission. Autophagy. 2015;11:1259\u201379.","journal-title":"Autophagy"},{"key":"8703_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.619730","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Z, Shu S, Cai J, Tang C, Dong Z. AMPK\/mTOR signaling in autophagy regulation during cisplatin-induced acute kidney injury. Front Physiol. 2020;11:619730.","journal-title":"Front Physiol"},{"key":"8703_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402030","volume":"11","author":"P Deng","year":"2024","unstructured":"Deng P, Fan T, Gao P, Peng Y, Li M, Li J, et al. SIRT5-mediated desuccinylation of RAB7A protects against cadmium-induced Alzheimer\u2019s disease-like pathology by restoring autophagic flux. Adv Sci (Weinh). 2024;11:e2402030.","journal-title":"Adv Sci (Weinh)"},{"key":"8703_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1080\/15548627.2023.2180202","volume":"19","author":"BK Jung","year":"2023","unstructured":"Jung BK, Park Y, Yoon B, Bae JS, Han SW, Heo JE, et al. Reduced secretion of LCN2 (lipocalin 2) from reactive astrocytes through autophagic and proteasomal regulation alleviates inflammatory stress and neuronal damage. Autophagy. 2023;19:2296\u2013317.","journal-title":"Autophagy"},{"key":"8703_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/aps.2012.184","volume":"34","author":"XJ Zhang","year":"2013","unstructured":"Zhang XJ, Chen S, Huang KX, Le WD. Why should autophagic flux be assessed?. Acta Pharm Sin. 2013;34:595\u20139.","journal-title":"Acta Pharm Sin"},{"key":"8703_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jare.2023.04.002","volume":"56","author":"G Chen","year":"2024","unstructured":"Chen G, Gao C, Jiang S, Cai Q, Li R, Sun Q, et al. Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis. J Adv Res. 2024;56:167\u201379.","journal-title":"J Adv Res"},{"key":"8703_CR21","doi-asserted-by":"crossref","unstructured":"Izdebska M, Zielinska W, Halas-Wisniewska M, Grzanka A. Involvement of actin in autophagy and autophagy-dependent multidrug resistance in cancer. Cancers. 2019;11:1209.","DOI":"10.3390\/cancers11081209"},{"key":"8703_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jare.2024.01.028","volume":"67","author":"Y Chen","year":"2025","unstructured":"Chen Y, Shen J, Yuan M, Li H, Li Y, Zheng S, et al. Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux. J Adv Res. 2025;67:331\u201348.","journal-title":"J Adv Res"},{"key":"8703_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12:401\u201310.","journal-title":"Nat Rev Cancer"},{"key":"8703_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.350","volume":"4","author":"X Sui","year":"2013","unstructured":"Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838.","journal-title":"Cell Death Dis"},{"key":"8703_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2022.01.002","volume":"531","author":"G Pan","year":"2022","unstructured":"Pan G, Zhang K, Geng S, Lan C, Hu X, Li C, et al. PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer. Cancer Lett. 2022;531:109\u201323.","journal-title":"Cancer Lett"},{"key":"8703_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-019-0368-8","volume":"25","author":"KL Bryant","year":"2019","unstructured":"Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019;25:628\u201340.","journal-title":"Nat Med"},{"key":"8703_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117759","volume":"324","author":"X Hu","year":"2024","unstructured":"Hu X, Li J, Yu L, Ifejola J, Guo Y, Zhang D, et al. Screening of anti-melanoma compounds from Morus alba L.: Sanggenon C promotes melanoma cell apoptosis by disrupting intracellular Ca(2+) homeostasis. J Ethnopharmacol. 2024;324:117759.","journal-title":"J Ethnopharmacol"},{"key":"8703_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1007279","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, Zhang K, Pan G, Wang Y, Shen Y, Peng C, et al. Cortex Mori extracts induce apoptosis and inhibit tumor invasion via blockage of the PI3K\/AKT signaling in melanoma cells. Front Pharm. 2022;13:1007279.","journal-title":"Front Pharm"},{"key":"8703_CR29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1080\/15548627.2016.1191722","volume":"12","author":"X Li","year":"2016","unstructured":"Li X, Zhu F, Jiang J, Sun C, Zhong Q, Shen M, et al. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells. Autophagy. 2016;12:1521\u201337.","journal-title":"Autophagy"},{"key":"8703_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1080\/15548627.2022.2138687","volume":"19","author":"S Iachettini","year":"2023","unstructured":"Iachettini S, Ciccarone F, Maresca C, D\u2032Angelo C, Petti E, Di Vito S, et al. The telomeric protein TERF2\/TRF2 impairs HMGB1-driven autophagy. Autophagy. 2023;19:1479\u201390.","journal-title":"Autophagy"},{"key":"8703_CR31","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","volume":"83","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zeng W, Han Y, Lee WR, Liou J, Jiang Y. Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel. Mol Cell. 2023;83:2524\u201339.e7.","journal-title":"Mol Cell"},{"key":"8703_CR32","first-page":"217","volume":"5","author":"YY Zhou","year":"1984","unstructured":"Zhou YY, Wang HY, Tang ZG, Ma DL. Two new formulae for evaluating effectiveness of drug combinations and revision of Burgi\u2019s and Jin\u2019s modified Burgi\u2019s formula. Zhongguo Yao Li Xue Bao. 1984;5:217\u201321.","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"8703_CR33","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1200\/JCO.23.00179","volume":"41","author":"H Kenmotsu","year":"2023","unstructured":"Kenmotsu H, Yamamoto N, Misumi T, Yoh K, Saito H, Sugawara S, et al. Five-year overall survival analysis of the JIPANG study: pemetrexed or vinorelbine plus cisplatin for resected stage II-IIIA nonsquamous non-small-cell lung cancer. J Clin Oncol. 2023;41:5242\u20136.","journal-title":"J Clin Oncol"},{"key":"8703_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0305-7372(80)80002-8","volume":"7","author":"BT Hill","year":"1980","unstructured":"Hill BT, Whelan RD. Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro. Cancer Treat Rev. 1980;7:5\u201315.","journal-title":"Cancer Treat Rev"},{"key":"8703_CR35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1182\/blood.V60.2.474.474","volume":"60","author":"JG White","year":"1982","unstructured":"White JG, Rao GH. Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood. 1982;60:474\u201383.","journal-title":"Blood"},{"key":"8703_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u20136.","journal-title":"Cancer Res"},{"key":"8703_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jhep.2025.03.028","volume":"83","author":"GY Lv","year":"2025","unstructured":"Lv GY, Mu WT, Cao YN, Sun XD, Wei F, Chai KY, et al. Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinoma. J Hepatol. 2025;83:917\u201330.","journal-title":"J Hepatol"},{"key":"8703_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101037","volume":"57","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhou P, Wu T, Zhang L, Kang J, Liao J, et al. Metformin combined with cisplatin reduces anticancer activity via ATM\/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer. Neoplasia. 2024;57:101037.","journal-title":"Neoplasia"},{"key":"8703_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100933","volume":"68","author":"C Zhu","year":"2023","unstructured":"Zhu C, Xie Y, Li Q, Zhang Z, Chen J, Zhang K, et al. CPSF6-mediated XBP1 3\u2019UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma. Drug Resist Updat. 2023;68:100933.","journal-title":"Drug Resist Updat"},{"key":"8703_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1371-1","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, He LR, Gao Y, Zhou NN, Liu Y, Zhou XK, et al. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-kappaB axis in human non-small-cell lung cancer. Cell Death Dis. 2019;10:99.","journal-title":"Cell Death Dis"},{"key":"8703_CR41","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(73)91318-4","volume":"1","author":"DC Tormey","year":"1973","unstructured":"Tormey DC. Neurotoxicity of vincristine. Lancet. 1973;1:1312.","journal-title":"Lancet"},{"key":"8703_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharm. 2014;740:364\u201378.","journal-title":"Eur J Pharm"},{"key":"8703_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13540-4","volume":"10","author":"C Kumsta","year":"2019","unstructured":"Kumsta C, Chang JT, Lee R, Tan EP, Yang Y, Loureiro R, et al. The autophagy receptor p62\/SQST-1 promotes proteostasis and longevity in C. elegans by inducing autophagy. Nat Commun. 2019;10:5648.","journal-title":"Nat Commun"},{"key":"8703_CR44","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1158\/1078-0432.CCR-16-1903","volume":"23","author":"JE Jang","year":"2017","unstructured":"Jang JE, Eom JI, Jeung HK, Cheong JW, Lee JY, Kim JS, et al. AMPK-ULK1-mediated autophagy confers resistance to BET inhibitor JQ1 in acute myeloid leukemia stem cells. Clin Cancer Res. 2017;23:2781\u201394.","journal-title":"Clin Cancer Res"},{"key":"8703_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-021-01915-9","volume":"40","author":"C Li","year":"2021","unstructured":"Li C, Zhang K, Pan G, Ji H, Li C, Wang X, et al. Dehydrodiisoeugenol inhibits colorectal cancer growth by endoplasmic reticulum stress-induced autophagic pathways. J Exp Clin Cancer Res. 2021;40:125.","journal-title":"J Exp Clin Cancer Res"},{"key":"8703_CR46","doi-asserted-by":"crossref","unstructured":"Zhang K, Hu X, Su J, Li D, Thakur A, Gujar V, et al. Gastrointestinal cancer therapeutics via triggering unfolded protein response and endoplasmic reticulum stress by 2-arylbenzofuran. Int J Mol Sci. 2024;25:999.","DOI":"10.3390\/ijms25020999"},{"key":"8703_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ki.1994.6","volume":"45","author":"MJ Ryan","year":"1994","unstructured":"Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994;45:48\u201357.","journal-title":"Kidney Int"},{"key":"8703_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u201341.","journal-title":"Nat Cell Biol"},{"key":"8703_CR49","doi-asserted-by":"publisher","first-page":"13768","DOI":"10.1021\/acs.jafc.3c02257","volume":"71","author":"X Hu","year":"2023","unstructured":"Hu X, Pan G, Luo J, Gao X, Mu Y, Wang Z, et al. Kuwanon H inhibits melanoma growth through cytotoxic endoplasmic reticulum stress and impaired autophagy flux. J Agric Food Chem. 2023;71:13768\u201382.","journal-title":"J Agric Food Chem"},{"key":"8703_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1083\/jcb.90.3.665","volume":"90","author":"B Poole","year":"1981","unstructured":"Poole B, Ohkuma S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol. 1981;90:665\u20139.","journal-title":"J Cell Biol"},{"key":"8703_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217809","volume":"625","author":"GP Nagaraju","year":"2025","unstructured":"Nagaraju GP, Saddala MS, Sarvesh S, Bandi DSR, Khaliq AM, Masood A, et al. Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: a single cell RNA-seq analysis. Cancer Lett. 2025;625:217809.","journal-title":"Cancer Lett"},{"key":"8703_CR52","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.18632\/aging.202653","volume":"13","author":"L Yuan","year":"2021","unstructured":"Yuan L, Yuan Y, Liu F, Li L, Liu J, Chen Y, et al. PGC-1alpha alleviates mitochondrial dysfunction via TFEB-mediated autophagy in cisplatin-induced acute kidney injury. Aging. 2021;13:8421\u201339.","journal-title":"Aging"},{"key":"8703_CR53","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1080\/15548627.2021.1905466","volume":"17","author":"W Liu","year":"2021","unstructured":"Liu W, Xu L, Wang X, Zhang D, Sun G, Wang M, et al. PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage. Autophagy. 2021;17:4159\u201381.","journal-title":"Autophagy"},{"key":"8703_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep23975","volume":"6","author":"J Li","year":"2016","unstructured":"Li J, Gui Y, Ren J, Liu X, Feng Y, Zeng Z, et al. Metformin protects against cisplatin-induced tubular cell apoptosis and acute kidney injury via AMPKalpha-regulated autophagy induction. Sci Rep. 2016;6:23975.","journal-title":"Sci Rep"},{"key":"8703_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/aps.2015.114","volume":"37","author":"H Liu","year":"2016","unstructured":"Liu H, Gu LB, Tu Y, Hu H, Huang YR, Sun W. Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy. Acta Pharm Sin. 2016;37:235\u201345.","journal-title":"Acta Pharm Sin"},{"key":"8703_CR56","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbrc.2017.01.180","volume":"484","author":"H Li","year":"2017","unstructured":"Li H, Tang Y, Wen L, Kong X, Chen X, Liu P, et al. Neferine reduces cisplatin-induced nephrotoxicity by enhancing autophagy via the AMPK\/mTOR signaling pathway. Biochem Biophys Res Commun. 2017;484:694\u2013701.","journal-title":"Biochem Biophys Res Commun"},{"key":"8703_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bcp.2010.12.026","volume":"81","author":"S Sertel","year":"2011","unstructured":"Sertel S, Fu Y, Zu Y, Rebacz B, Konkimalla B, Plinkert PK, et al. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine. Biochem Pharm. 2011;81:723\u201335.","journal-title":"Biochem Pharm"},{"key":"8703_CR58","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-22-3023","volume":"83","author":"F Exposito","year":"2023","unstructured":"Exposito F, Redrado M, Houry M, Hastings K, Molero-Abraham M, Lozano T, et al. PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer Res. 2023;83:2513\u201326.","journal-title":"Cancer Res"},{"key":"8703_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138.","journal-title":"Mol Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08703-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08703-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:02:29Z","timestamp":1780549349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08703-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8703"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08703-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}